Lifevantage Corp (LFVN)

$6.93

+0.33

(+5%)

Market is closed - opens 7 PM, 25 Jul 2024

Performance

  • $6.59
    $7.12
    $6.93
    downward going graph

    4.91%

    Downside

    Day's Volatility :7.44%

    Upside

    2.67%

    downward going graph
  • $3.90
    $8.42
    $6.93
    downward going graph

    43.72%

    Downside

    52 Weeks Volatility :53.68%

    Upside

    17.7%

    downward going graph

Returns

PeriodLifevantage CorpIndex (Russel 2000)
3 Months
6.97%
0.0%
6 Months
18.49%
0.0%
1 Year
33.6%
0.0%
3 Years
-21.24%
-19.9%

Highlights

Market Capitalization
82.2M
Book Value
$2.11
Dividend Share
0.14
Dividend Yield
2.47%
Earnings Per Share (EPS)
0.28
PE Ratio
23.11
PEG Ratio
0.0
Wall Street Target Price
7.0
Profit Margin
1.75%
Operating Margin TTM
4.01%
Return On Assets TTM
3.53%
Return On Equity TTM
11.95%
Revenue TTM
205.5M
Revenue Per Share TTM
16.37
Quarterly Revenue Growth YOY
-10.2%
Gross Profit TTM
170.0M
EBITDA
7.3M
Diluted Eps TTM
0.28
Quarterly Earnings Growth YOY
0.63
EPS Estimate Current Year
0.65
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.16
EPS Estimate Next Quarter
0.21

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Lifevantage Corp(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1.01%

Current $6.93
Target $7.00

Company Financials

FY18Y/Y Change
Revenue
203.2M
↑ 1.86%
Net Income
5.8M
↑ 258.27%
Net Profit Margin
2.84%
↑ 2.03%
FY19Y/Y Change
Revenue
226.0M
↑ 11.2%
Net Income
7.4M
↑ 28.95%
Net Profit Margin
3.29%
↑ 0.45%
FY20Y/Y Change
Revenue
232.9M
↑ 3.08%
Net Income
11.5M
↑ 55.46%
Net Profit Margin
4.96%
↑ 1.67%
FY21Y/Y Change
Revenue
220.2M
↓ 5.47%
Net Income
12.9M
↑ 11.65%
Net Profit Margin
5.86%
↑ 0.9%
FY22Y/Y Change
Revenue
206.4M
↓ 6.28%
Net Income
3.1M
↓ 75.8%
Net Profit Margin
1.51%
↓ 4.35%
FY23Y/Y Change
Revenue
213.4M
↑ 3.41%
Net Income
2.5M
↓ 18.59%
Net Profit Margin
1.19%
↓ 0.32%
Q4 FY22Q/Q Change
Revenue
53.7M
↑ 3.65%
Net Income
-1.1M
↓ 273.44%
Net Profit Margin
-1.97%
↓ 3.15%
Q1 FY23Q/Q Change
Revenue
53.7M
↑ 0.15%
Net Income
1.0M
↓ 196.6%
Net Profit Margin
1.9%
↑ 3.87%
Q2 FY23Q/Q Change
Revenue
54.2M
↑ 0.89%
Net Income
2.0M
↑ 92.37%
Net Profit Margin
3.63%
↑ 1.73%
Q3 FY23Q/Q Change
Revenue
51.4M
↓ 5.27%
Net Income
629.0K
↓ 68.01%
Net Profit Margin
1.22%
↓ 2.41%
Q4 FY23Q/Q Change
Revenue
51.6M
↑ 0.51%
Net Income
-656.0K
↓ 204.29%
Net Profit Margin
-1.27%
↓ 2.49%
Q1 FY24Q/Q Change
Revenue
48.2M
↓ 6.55%
Net Income
1.7M
↓ 352.9%
Net Profit Margin
3.44%
↑ 4.71%
FY18Y/Y Change
Total Assets
51.1M
↑ 13.02%
Total Liabilities
29.2M
↓ 4.97%
FY19Y/Y Change
Total Assets
55.3M
↑ 8.08%
Total Liabilities
28.1M
↓ 3.84%
FY20Y/Y Change
Total Assets
58.9M
↑ 6.52%
Total Liabilities
25.6M
↓ 8.73%
FY21Y/Y Change
Total Assets
78.7M
↑ 33.72%
Total Liabilities
41.9M
↑ 63.62%
FY22Y/Y Change
Total Assets
70.7M
↓ 10.19%
Total Liabilities
39.2M
↓ 6.52%
FY23Y/Y Change
Total Assets
66.1M
↓ 6.48%
Total Liabilities
31.5M
↓ 19.69%
Q4 FY22Q/Q Change
Total Assets
67.8M
↑ 0.34%
Total Liabilities
35.9M
↑ 0.64%
Q1 FY23Q/Q Change
Total Assets
67.1M
↓ 1.11%
Total Liabilities
33.6M
↓ 6.39%
Q2 FY23Q/Q Change
Total Assets
66.1M
↓ 1.43%
Total Liabilities
31.5M
↓ 6.44%
Q3 FY23Q/Q Change
Total Assets
66.6M
↑ 0.73%
Total Liabilities
37.3M
↑ 18.54%
Q4 FY23Q/Q Change
Total Assets
62.7M
↓ 5.89%
Total Liabilities
35.4M
↓ 5.19%
Q1 FY24Q/Q Change
Total Assets
61.3M
↓ 2.19%
Total Liabilities
34.5M
↓ 2.37%
FY18Y/Y Change
Operating Cash Flow
13.3M
↑ 100.94%
Investing Cash Flow
-4.6M
↑ 340.66%
Financing Cash Flow
-3.5M
↑ 78.7%
FY19Y/Y Change
Operating Cash Flow
17.8M
↑ 34.2%
Investing Cash Flow
-4.5M
↓ 3.08%
Financing Cash Flow
-11.1M
↑ 217.83%
FY20Y/Y Change
Operating Cash Flow
18.3M
↑ 3.02%
Investing Cash Flow
-2.7M
↓ 40.5%
Financing Cash Flow
-12.4M
↑ 11.7%
FY21Y/Y Change
Operating Cash Flow
16.3M
↓ 11.2%
Investing Cash Flow
-3.7M
↑ 39.28%
Financing Cash Flow
-11.5M
↓ 7.8%
FY22Y/Y Change
Operating Cash Flow
8.0M
↓ 51.09%
Investing Cash Flow
-1.5M
↓ 59.03%
Financing Cash Flow
-9.0M
↓ 21.84%
FY23Y/Y Change
Operating Cash Flow
6.8M
↓ 14.21%
Investing Cash Flow
-3.1M
↑ 99.93%
Financing Cash Flow
-2.4M
↓ 73.67%
Q4 FY22Q/Q Change
Operating Cash Flow
967.0K
↓ 171.9%
Investing Cash Flow
-837.0K
↑ 15.13%
Financing Cash Flow
-400.0K
↑ 21.95%
Q1 FY23Q/Q Change
Operating Cash Flow
3.4M
↑ 256.05%
Investing Cash Flow
-505.0K
↓ 39.67%
Financing Cash Flow
-306.0K
↓ 23.5%
Q2 FY23Q/Q Change
Operating Cash Flow
3.8M
↑ 9.29%
Investing Cash Flow
-505.0K
↑ 0.0%
Financing Cash Flow
-1.3M
↑ 332.35%

Technicals Summary

Sell

Neutral

Buy

Lifevantage Corp is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lifevantage Corp
Lifevantage Corp
1.54%
18.49%
33.6%
-21.24%
-42.26%
Kraft Heinz Company, The
Kraft Heinz Company, The
-1.23%
-10.92%
-9.77%
-17.0%
2.28%
Mccormick & Company, Incorporated
Mccormick & Company, Incorporated
6.85%
12.4%
-16.71%
-13.4%
-6.89%
Hormel Foods Corporation
Hormel Foods Corporation
0.71%
2.57%
-23.05%
-34.02%
-22.84%
General Mills, Inc.
General Mills, Inc.
-5.99%
0.55%
-17.17%
7.87%
21.1%
Kellanova
Kellanova
-2.83%
5.87%
-16.57%
-10.5%
-2.83%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lifevantage Corp
Lifevantage Corp
23.11
23.11
0.0
0.65
0.12
0.04
0.02
2.11
Kraft Heinz Company, The
Kraft Heinz Company, The
14.29
14.29
1.02
3.01
0.06
0.04
0.05
40.79
Mccormick & Company, Incorporated
Mccormick & Company, Incorporated
26.8
26.8
2.48
2.86
0.14
0.05
0.02
19.83
Hormel Foods Corporation
Hormel Foods Corporation
22.39
22.39
2.96
1.6
0.1
0.05
0.04
14.39
General Mills, Inc.
General Mills, Inc.
14.99
14.99
1.98
4.5
0.25
0.07
0.04
16.81
Kellanova
Kellanova
24.41
24.41
2.93
3.62
0.21
0.05
0.04
9.24
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lifevantage Corp
Lifevantage Corp
Buy
$82.2M
-42.26%
23.11
1.75%
Kraft Heinz Company, The
Kraft Heinz Company, The
Buy
$39.8B
2.28%
14.29
10.62%
Mccormick & Company, Incorporated
Mccormick & Company, Incorporated
Hold
$19.7B
-6.89%
26.8
11.07%
Hormel Foods Corporation
Hormel Foods Corporation
Hold
$17.2B
-22.84%
22.39
6.37%
General Mills, Inc.
General Mills, Inc.
Hold
$36.1B
21.1%
14.99
12.57%
Kellanova
Kellanova
Hold
$19.7B
-2.83%
24.41
7.09%

Insights on Lifevantage Corp

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 51.62M → 48.24M (in $), with an average decrease of 6.6% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -656.0K → 1.65M (in $), with an average increase of 139.5% per quarter

  • Vs GIS

    In the last 3 years, Lifevantage Corp has experienced a drawdown of -20.4%, however General Mills, Inc. resisted the overall trend and outperformed by 4.0%

Institutional Holdings

  • Renaissance Technologies Corp

    6.60%
  • Vanguard Group Inc

    3.74%
  • Dimensional Fund Advisors, Inc.

    2.44%
  • Acadian Asset Management LLC

    1.80%
  • BlackRock Inc

    1.61%
  • Empowered Funds, LLC

    1.20%

Company Information

lifevantage is at the forefront of nutrigenomics, a new form of nutritional science that uses nutrients to create improved health and wellness. aging is inevitable. and we’re all painfully aware of the toll it takes on our bodies. nutrigenomics is serious science. and it’s graduated from the laboratory to real-life, creating a platform for products that really work – really.

Organization
Lifevantage Corp
Employees
248
CEO
Mr. Steven R. Fife
Industry
Health Technology

FAQs